WashU joins Third Coast Foundry
WashU is an inaugural member of Third Coast Foundry, a new initiative designed to strengthen the combined presence of Midwestern universities in the San Francisco Bay Area.
Powering our future
Alumnus Calvin Butler brings forward-looking energy to Exelon, a Fortune 200 utility company.
Wine, cheese and the law of entrepreneurship
Alumnus Vijay Shroff’s background as an attorney helps him prioritize community and collaboration in business.
All in the family
In her business and engagement with WashU, Lynn Gorguze prioritizes relationships and building community.
A future-ready leader takes her shot
On-campus leadership opportunities put Christina Walker on a path to help future student-athletes thrive.
Steensma installed as E. Desmond and Mary Ann Lee Professor
Public health scholar and entrepreneur Joseph T. Steensma bridges research and real-world impact, translating science into scalable solutions that address environmental and population health challenges.
Olin to host ‘Business of Being Well’ March 31
WashU Olin Business School will host its annual spring symposium, aimed at improving health outcomes. The daylong event offers participants business-driven perspectives on health and the chance to connect with peers from WashU and beyond.
Four named senior members of National Academy of Inventors
Four WashU researchers have been named senior members of the National Academy of Inventors: Rajan Chakrabarty, Vijay Ramani, Christina Stallings and Zhude Tu.
WashU among top 100 granted US patents
WashU has been named to the National Academy of Inventors’ Top 100 Worldwide Universities granted U.S. utility patents in 2025. The university is ranked 49 on the list, with 70 total patents.
Why prescription drug prices stay high — and what Congress can do about it
High prescription drug prices are not caused by any single company or practice, but by the system itself, said WashU Law’s Rachel Sachs. If Congress wants lower drug prices, it has to fix the structure and incentives of the entire supply chain, said Sachs, an expert on prescription drug pricing.
Older Stories